The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 33662300.
- Also identified by DOI 10.1016/S1470-2045(20)30590-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For patients diagnosed with cancer who have previously received an organ transplant, radiotherapy represents a challenging clinical scenario without well established care algorithms. Immunosuppressive therapy can be a cause for concern among clinicians treating this category of patients. Potential immune modulation following irradiation could affect recipient organ tolerance and the outcomes of the transplantation itself. The main aim of this systematic review was to define the safety and effectiveness of radiotherapy in patients diagnosed with cancer who have previously received an organ transplant. We searched PubMed and Embase for articles published between Jan 1, 1995, and April 30, 2020 for studies in patients who had undergone radiotherapy for post-transplantation malignancies. The Review is framed by the PICO (population, intervention, control, and outcomes) criteria, and primarily focuses on modern treatment techniques.
Medical subject headings
- Immunosuppression Therapy
- Neoplasms
- Organ Transplantation
- Radiation Oncology